Sandi Greenwood has 20-plus years of investment and analyst experience in the global healthcare sector. She spent 14 years at Ninety One (formerly Investec Asset Management) as a global healthcare equity analyst and product specialist. In addition to this, she has worked in Investment Research as a pharma analyst at ABN Amro (London) and Merrill Lynch (South Africa). Sandi has a Bachelor of Commerce from the University of Witwatersrand and an Economics degree from the University of South Africa.